The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AusPAR: Keytruda
Australian Public Assessment Report
Device/Product Name
Keytruda
Active ingredients
Pembrolizumab
AusPAR Date
Published
Submission Number
PM-2021-04316-1-4
Submission Type
Extension of indications
Decision
Approved